Giuseppe Valenza1,2, Monika Schulze3, Petra Friedrich3, Wulf Schneider-Brachert4, Thomas Holzmann4, Silke Nickel1, Verena Lehner-Reindl1, Christiane Höller5. 1. a Bavarian Health and Food Safety Authority , Erlangen , Germany. 2. b Microbiology Institute - Clinical Microbiology, Immunology and Hygiene , University Hospital of Erlangen , Erlangen , Germany. 3. c Department of Hygiene and Environmental Medicine , Central Hospital of Augsburg , Augsburg , Germany. 4. d Institute of Clinical Microbiology and Hygiene , University Hospital of Regensburg , Regensburg , Germany. 5. e Bavarian Health and Food Safety Authority , Oberschleißheim , Germany.
Abstract
BACKGROUND: Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are spreading worldwide in both hospital and community settings. In this study, the molecular epidemiology and the transmission modalities of ESBL-E in intensive care- and bone marrow transplant were investigated. METHODS: All patients included in this study were screened for presence of ESBL-E on admission and weekly. Relevant β-lactamase genes were identified by PCR and sequencing. RESULTS: A total of 669 patients were included in this study. On admission, ESBL-producing Escherichia coli were detected in 49 (7.3%) patients and ESBL-producing Klebsiella pneumoniae in one patient. The most common ESBL types among E. coli isolates were CTX-M-15 (38.8%) and CTX-M-1 (38.8%). Furthermore, 12 of 49 (24.5%) ESBL-producing E. coli could be assigned to the epidemic clone ST131. A single patient acquired ESBL-producing E. coli during the hospital stay but cross-transmission could not be demonstrated. Among 1095 environmental samples none revealed ESBL. CONCLUSIONS: Our results suggest that early detection of ESBL-producing Enterobacteriaceae and consequent implementation of basic hygiene measures and contact isolation may reduce the transmission rate during the hospital stay.
BACKGROUND: Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are spreading worldwide in both hospital and community settings. In this study, the molecular epidemiology and the transmission modalities of ESBL-E in intensive care- and bone marrow transplant were investigated. METHODS: All patients included in this study were screened for presence of ESBL-E on admission and weekly. Relevant β-lactamase genes were identified by PCR and sequencing. RESULTS: A total of 669 patients were included in this study. On admission, ESBL-producing Escherichia coli were detected in 49 (7.3%) patients and ESBL-producing Klebsiella pneumoniae in one patient. The most common ESBL types among E. coli isolates were CTX-M-15 (38.8%) and CTX-M-1 (38.8%). Furthermore, 12 of 49 (24.5%) ESBL-producing E. coli could be assigned to the epidemic clone ST131. A single patient acquired ESBL-producing E. coli during the hospital stay but cross-transmission could not be demonstrated. Among 1095 environmental samples none revealed ESBL. CONCLUSIONS: Our results suggest that early detection of ESBL-producing Enterobacteriaceae and consequent implementation of basic hygiene measures and contact isolation may reduce the transmission rate during the hospital stay.
Authors: Lutz Ehlkes; Yvonne Pfeifer; Guido Werner; Ralf Ignatius; Manfred Vogt; Tim Eckmanns; Philipp Zanger; Jan Walter Journal: Euro Surveill Date: 2019-02
Authors: Kira Schmitt; Stefan P Kuster; Katrin Zurfluh; Rahel S Jud; Jane E Sykes; Roger Stephan; Barbara Willi Journal: Antibiotics (Basel) Date: 2021-02-09
Authors: Dennis Souverein; Sjoerd M Euser; Bjorn L Herpers; Jan Kluytmans; John W A Rossen; Jeroen W Den Boer Journal: PLoS One Date: 2019-01-25 Impact factor: 3.240